| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/12/2012 | US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
| 01/12/2012 | US20120010193 Cgrp receptor antagonists |
| 01/12/2012 | US20120010192 Fused Heterocyclic Compounds as Ion Channel Modulators |
| 01/12/2012 | US20120010188 Imidazopyridine Compounds |
| 01/12/2012 | US20120010186 Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/12/2012 | US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |
| 01/12/2012 | US20120009144 Heterocyclic antiviral compounds |
| 01/12/2012 | US20120007069 Novel nitrogen-containing heterocyclic compound and organic electronic device using the same |
| 01/12/2012 | DE102010031149A1 New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful to treat and/or prevent heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, and vascular disease |
| 01/12/2012 | DE102010031148A1 New 1-(2-fluoro-benzyl)-1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful to treat and/or prevent heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, and vascular disease |
| 01/12/2012 | CA2805065A1 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof |
| 01/12/2012 | CA2804915A1 Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof |
| 01/12/2012 | CA2804285A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 01/12/2012 | CA2804161A1 Pro-neurogenic compounds |
| 01/12/2012 | CA2803448A1 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| 01/12/2012 | CA2802216A1 Tetrahydrocarboline derivative |
| 01/12/2012 | CA2802132A1 Tetrahydro-pyrido-pyrimidine derivatives |
| 01/12/2012 | CA2801670A1 Heterocyclic antiviral compounds |
| 01/12/2012 | CA2767516A1 Continuous flow process for the preparation of sulphoxide compounds |
| 01/11/2012 | EP2404923A1 7-azabicyclo[2.2.1]heptane derivatives useful for promoting smoking cessation |
| 01/11/2012 | EP2404904A1 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | EP2403831A1 SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLOÝ3,4-b¨PYRIDINE |
| 01/11/2012 | EP1881983B1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 01/11/2012 | EP1846406B9 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 01/11/2012 | EP1569904B1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 01/11/2012 | EP1566380B1 Isoquinoline compounds and medicinal use thereof |
| 01/11/2012 | CN1980925B Substituted azachinazolines having an antiviral action |
| 01/11/2012 | CN102317289A Lactams as beta secretase inhibitors |
| 01/11/2012 | CN102317288A [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors |
| 01/11/2012 | CN102317287A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 01/11/2012 | CN102311436A Preparation method of isorhynchophylline |
| 01/11/2012 | CN102311435A Preparation method for high purity rhynchophylline |
| 01/11/2012 | CN102311434A Evodiamine compounds, preparation method thereof and application thereof |
| 01/11/2012 | CN102311433A One-pot preparation method of imidazo[1,2-a]pyridine-3-acetic acid |
| 01/11/2012 | CN102311378A Fused pyrazole derivatives and uses thereof in methods of treatment of metabolic-related disorders |
| 01/11/2012 | CN101830901B Selenite ion type compound and preparation method and application thereof |
| 01/11/2012 | CN101528226B Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 01/11/2012 | CN101362755B Sulfosulfuron preparation method |
| 01/11/2012 | CN101346437B Trisazo compound, ink composition, recording method and colored matter |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093388 3-aza spiro[5,5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/10/2012 | US8093381 Method of synthesis of fluoroquinolones |
| 01/10/2012 | US8093343 Nitric oxide-releasing diazeniumdiolated compounds |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8093263 Substituted pyrazolo [1,5-a] pyrimidines as metabotropic glutamate antagonists |
| 01/10/2012 | US8093257 [6,5]-bicyclic GPR119 G protein-coupled receptor agonists |
| 01/10/2012 | US8093254 Aspartyl protease inhibitors |
| 01/10/2012 | CA2708442C A process for preparing n-(2-halo-4-methyl-3-pyridinyl)-2-(cyclopropylamino)-3-pyridinecarboxamide, an intermediate of nevirapine |
| 01/10/2012 | CA2625502C 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 01/10/2012 | CA2382105C Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 01/05/2012 | WO2012003418A2 Functionally selective ligands of dopamine d2 receptors |
| 01/05/2012 | WO2012003392A1 Fused heterocyclic compounds as ion channel modulators |
| 01/05/2012 | WO2012003283A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | WO2012002680A2 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 01/05/2012 | WO2012002577A1 Novel nicotinamide derivatives or salts thereof |
| 01/05/2012 | WO2012002568A1 Azaindole derivative |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | WO2012002284A1 Light emitting element, photoelectric conversion element, method for producing light emitting element, and method for producing photoelectric conversion element |
| 01/05/2012 | WO2012001040A1 Novel microbiocidal dioxime ether derivatives |
| 01/05/2012 | WO2012001020A1 Novel tetrahydroquinoline derivatives |
| 01/05/2012 | WO2012000632A1 Pyrazolo-quinolines |
| 01/05/2012 | WO2012000595A1 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 01/05/2012 | WO2012000519A1 Aryl- and heteroarylamid derivatives as pde10a enzyme inhibitor |
| 01/05/2012 | WO2012000304A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | WO2011142825A3 Novel sulfur containing compounds |
| 01/05/2012 | WO2011103007A3 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells |
| 01/05/2012 | WO2010134846A8 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same |
| 01/05/2012 | US20120004349 Epoxy resin composition, curing agent, and curing accelerator |
| 01/05/2012 | US20120004243 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 01/05/2012 | US20120004239 Process for Preparing Quinoxaline Derivatives |
| 01/05/2012 | US20120004233 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 01/05/2012 | US20120004227 Cyclohexane derivative having npy y5 receptor antagonism |
| 01/05/2012 | US20120004223 Compounds, compositions and methods for reducing lipid levels |
| 01/05/2012 | US20120004222 Cb2 receptor ligands for the treatment of pain |
| 01/05/2012 | US20120004218 Novel tetrahydro-quinoline derivatives |
| 01/05/2012 | US20120004215 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004201 Phosphodiestarase inhibitors |
| 01/05/2012 | US20120003153 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 01/05/2012 | DE102010025786A1 Pyrazolochinoline Pyrazolochinoline |
| 01/05/2012 | CA2804347A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/05/2012 | CA2804069A1 Pyrazoloquinolines |
| 01/05/2012 | CA2803842A1 Novel nicotinamide derivative or salt thereof |
| 01/05/2012 | CA2803665A1 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 01/05/2012 | CA2803577A1 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 01/05/2012 | CA2803478A1 Novel tetrahydroquinoline derivatives |
| 01/05/2012 | CA2803358A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2802288A1 Fused heterocyclic compounds as ion channel modulators |
| 01/04/2012 | EP2402340A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402339A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402338A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402337A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402336A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402335A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402334A1 Inhibitors of E1 Activating Enzymes |
| 01/04/2012 | EP2402314A1 (Aza)indole derivative and use thereof for medical purposes |
| 01/04/2012 | EP2401915A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2401277A1 Salt of tetrahydrotriazolopyridine derivative and crystal thereof |